Rhinorrhea following SARS-CoV-2 nasopharyngeal swab: A case for β2-transferrin testing.

Eur J Neurol

Department of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria.

Published: November 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239899PMC
http://dx.doi.org/10.1111/ene.14883DOI Listing

Publication Analysis

Top Keywords

rhinorrhea sars-cov-2
4
sars-cov-2 nasopharyngeal
4
nasopharyngeal swab
4
swab case
4
case β2-transferrin
4
β2-transferrin testing
4
rhinorrhea
1
nasopharyngeal
1
swab
1
case
1

Similar Publications

Article Synopsis
  • The COVID-19 pandemic has presented major health challenges, particularly with the emergence of new SARS-CoV-2 variants throughout multiple waves of infection.
  • A study conducted in southern Bahia, Brazil, analyzed samples from two waves in late 2021 and 2022, revealing a significant increase in positivity rates and a shift from the Delta variant in 2021 to the Omicron variant in 2022.
  • Differences in clinical symptoms were noted, with anosmia/ageusia being common in 2021 but less frequent in 2022, and other symptoms like fever and cough being more prevalent in Omicron infections compared to Delta.
View Article and Find Full Text PDF

COVID-19 and influenza are highly contagious respiratory viral diseases and priority global public health concerns. We conducted a retrospective observational study of COVID-19 and/or influenza hospitalized cases, during 2023. We identified 170 influenza cases, 150 COVID-19 cases and 3 co-infections.

View Article and Find Full Text PDF

Background: This report analyzes traumatic anterior skull base CSF leaks following nasopharyngeal swab testing for detection of SARS-CoV-2 in the largest case series to date, combined with a systematic literature review.

Methods: Retrospective multi-institutional case-series of traumatic anterior skull base CSF leak with clear antecedent history of COVID-19 swab was completed. A comprehensive search of databases was performed for the systematic literature review.

View Article and Find Full Text PDF

Clinical Features and Vaccination Effects among Children with Post-Acute Sequelae of COVID-19 in Taiwan.

Vaccines (Basel)

August 2024

Center of Allergy, Immunology and Microbiome (A.I.M), China Medical University Hospital, China Medical University Children's Hospital, Taichung 40447, Taiwan.

Background: Post-acute sequelae of SARS-CoV-2 infection (PASC) affects patients after recovering from acute coronavirus disease 2019 (COVID-19). This study investigates the impact of SARS-CoV-2 vaccination on PASC symptoms in children in Taiwan during the Omicron pandemic.

Methods: We enrolled children under 18 years with PASC symptoms persisting for more than 4 weeks.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines symptom phenotypes of COVID-19 patients to identify subtypes with different outcomes and prognoses for better management of the disease.
  • It analyzes 14,139 electronic medical records from Hubei Province, employing deep learning and clustering algorithms to classify patients into three distinct subtypes based on their symptoms.
  • The identified subtypes reveal significant differences in prognosis, with Subtype 0 showing the highest mortality rate (4.72%) and specific symptom patterns that may help forecast patient outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!